Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1966364 | 0.86 | MAOA (0.41) | ALDH1A1CYP1A2HPGDHSD17B10THRB | |
| SCHEMBL309868 | 0.84 | MAOA (0.42) | ALDH1A1CYP1A2HPGDHSD17B10THRB | |
| SCHEMBL28461699 | 0.83 | PTPN1 (0.45) | ALDH1A1CYP1A2HPGDHSD17B10THRB | |
| Benzoquinone SCHEMBL27576817 | 0.83 | MAOA (0.41) | ALDH1A1CYP1A2HPGDHSD17B10THRB | |
| SCHEMBL29656951 | 0.75 | ALDH1A1 (0.64) | ALDH1A1CYP1A2HPGDHSD17B10THRB | |
| SCHEMBL16321276 | 0.75 | ALDH1A1 (0.64) | ALDH1A1CYP1A2HPGDHSD17B10THRB | |
| SCHEMBL197980 | 0.75 | PTPN1 (0.59) | ALDH1A1CYP1A2HPGDMAOAMAOB | |
| Bromide SCHEMBL28891253 | 0.75 | MAOA (0.40) | ALDH1A1CYP1A2HPGDHSD17B10MAOA | |
| SCHEMBL20599085 | 0.75 | MAOA (0.40) | ALDH1A1CYP1A2HPGDHSD17B10MAOA | |
| SCHEMBL28569068 | 0.74 | ALDH1A1 (0.54) | ALDH1A1CYP1A2HPGDHSD17B10MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 926 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622964-B2 | Modular phage vector platform for sonodynamic therapy | Alma Mater Studiorum—Universita' di Bologna (IT) | 2026-05-12 | — | — | US | claimed |
| EP-4713440-A1 | BACTERIOPHAGES AND USES THEREOF FOR TARGETING GD2-EXPRESSING TUMOR CELLS | Alma Mater Studiorum Universita di Bologna (IT) | 2026-03-25 | — | — | EP | claimed |
| CN-111542345-B | Chlorotoxin agent and use thereof | 卫材公司 | 2025-02-25 | — | — | CN | claimed |
| US-20240387851-A1 | PERYLENEQUINONES FOR REDOX APPLICATIONS | NATIONAL INSTITUTES OF HEALTH | 2024-11-21 | — | — | US | claimed |
| WO-2024236110-A1 | BACTERIOPHAGES AND USES THEREOF FOR TARGETING GD2-EXPRESSING TUMOR CELLS | ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) | 2024-11-21 | — | — | WO | claimed |
| CN-118576706-A | Perylenequinone supermolecule photosensitizer and preparation method and application thereof | 中国科学院理化技术研究所 | 2024-09-03 | — | — | CN | claimed |
| CN-117715942-A | Enhanced targeting using antibody-oligonucleotide conjugates | 代码生物疗法公司 | 2024-03-15 | — | — | CN | claimed |
| CN-117487674-A | Perylenequinone compound cercosporin A with enhanced photodynamic activity and application thereof | 江南大学 | 2024-02-02 | — | — | CN | claimed |
| CN-117487673-A | Method for producing dipre-cercosporin by fermentation | 江南大学 | 2024-02-02 | — | — | CN | claimed |
| EP-4301859-A1 | ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES | Code Biotherapeutics, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| EP-1015033-A2 | SUBSTITUTED PERYLENEQUINONES FOR USE IN PHOTODYNAMIC THERAPY | AltaRex, Corp. (CA) | 2000-07-05 | — | — | EP | claimed |
| US-5891870-A | ANTIINFLAMMATORY AGENTS USING BENZODITERPENES AND BENZOLACTAMS | PROCYON PHARMACEUTICALS, INC. (US) | 1999-04-06 | — | — | US | claimed |
| WO-1998033470-A2 | SUBSTITUTED PERYLENEQUINONES FOR USE IN PHOTODYNAMIC THERAPY | ALTAREX CORP. (CA) | 1998-08-06 | — | — | WO | claimed |
| EP-0635479-B1 | Perylene quinones (UCN-1028 D) derivatives | KYOWA HAKKO KOGYO KK (JP) | 1997-07-30 | — | — | EP | claimed |
| EP-0635479-A1 | Perylene quinones (UCN-1028 D) derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1995-01-25 | — | — | EP | claimed |
| US-5219627-A | Crystalline thermoplastic resin; one side smooth, the other rough; partially transparent displaying pigment at edges | CHISSO CORPORATION (JP) | 1993-06-15 | — | — | US | claimed |
| US-5140044-A | Antitumor and -carcinogenic agents; protein kinase C inhibitors | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1992-08-18 | — | — | US | claimed |
| EP-0451849-A2 | Surface-roughened rolled plate-like body containing pigment which transforms light into fluorescence | CHISSO CORPORATION (JP) | 1991-10-16 | — | — | EP | claimed |
| EP-0390181-A2 | Perylenequinone (UCN-1028D) derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-10-03 | — | — | EP | claimed |
| US-4309081-A | Display devices | BELL TELEPHONE LABORATORIES, INCORPORATED (US) | 1982-01-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622964-B2 | Modular phage vector platform for sonodynamic therapy | ERBB2, EGFR, ERBB3 | ALDH1A1 4689/4885CYP1A2 4556/4885HPGD 4783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.